XR8-89 is a potent papain-like protease (PL pro ) inhibitor with an IC 50 value of 0.1 μM. XR8-89 induces conformational changes in SARS-COV-2 papain-like protease, inhibiting SARS-CoV-2 replication. XR8-89 can be used for SARS-CoV-2 research
In Vitro
XR8-89 induces conformational changes manly in BL2 region and increases the activity against PL pro. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:IC50: 0.1 μM (papain-like protease)
规格
规格或纯度
≥97%
英文名称
XR8-89
生化机理
XR8-89 是一种强效的木瓜蛋白酶(PL pro )抑制剂,其 IC 50 值为 0.1 μM。XR8-89 可诱导 SARS-COV-2 木瓜蛋白酶发生构象变化,从而抑制 SARS-CoV-2 的复制。XR8-89 可用于 SARS-CoV-2 研究。